3billion, Inc. (KOSDAQ:394800)

South Korea · Delayed Price · Currency is KRW

15,220

-20 (-0.13%)

At close: Dec 5, 2025

163.78% (1Y)

Market Cap	482.80B
Revenue (ttm)	9.78B
Net Income (ttm)	-5.97B
Shares Out	31.72M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	982,860
Average Volume	1,700,320
Open	15,250
Previous Close	15,240
Day's Range	14,390 - 15,690
52-Week Range	4,670 - 15,550
Beta	n/a
RSI	80.02
Earnings Date	Mar 20, 2026

About 3billion

3billion, Inc. develops technology for rare disease drug discovery using bioinformatics and machine learning technology. The company focuses on developing methods for novel drug target discovery, drug candidate generation, and safety assessment. It offers genetic and biomolecular testing services related to the analysis of biologic samples of patients suspected to have rare genetic disorders, as well as provides various affiliated services to customers. The company was founded in 2016 and is based in Seoul, South Korea. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances

Founded 2016

Country South Korea

Stock Exchange KOSDAQ

Ticker Symbol 394800

Full Company Profile

Financial Performance

In 2024, 3billion's revenue was 5.77 billion, an increase of 111.41% compared to the previous year's 2.73 billion. Losses were -6.57 billion, 29.1% more than in 2023.

Financial Statements

News

There is no news available yet.